Latest News and Press Releases

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Germanium (GeCl4, GeO2, ZRG, SCG) - Global Markets, End-Users, Applications and Competitors" report from Dedalus Consulting has been added to ...

ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

OMA SAVINGS BANK PLC, INVESTOR NEWS 29.4.2026 AT 13.40 P.M. Oma Savings Bank Plc to publish its January-March 2026 interim report and hold a webcast on 7 May 2026 Oma Savings Bank Plc will publish...

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 29.4.2026 AT 13:40 EEST Resolutions of Huhtamäki Oyj’s Annual General Meeting of Shareholders and the organizational meeting of the Board of Directors Huhtamäki...

Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law

Fossar fjárfestingarbanki hf., kt. 660907-0250, Ármúla 3, 108 Reykjavík, hefur birt grunnlýsingu í tengslum við útgáfuramma víxla og skuldabréfa. Grunnlýsingin er dagsett 28. apríl 2026 og hefur verið...

Yimutian plans to adjust its ADS conversion ratio from 1 ADS representing 25 Class A ordinary shares to 375, effective around May 18, US. Eastern time.

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Powder Metallurgy - Global Markets by Process, End-Users, Applications and Competition" report from Dedalus Consulting has been added to ...

Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track...

Aspocomp Group Plc, Stock exchange release, April 29, 2026, at 1:30 p.m. (Finnish time)Decisions of Aspocomp Group Plc's Annual General Meeting 2026 and Board of Directors' organization meetingThe...